Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1998 Sep;74(875):543–544. doi: 10.1136/pgmj.74.875.543

Increased serum CA 19-9 antibodies in Sjögren's syndrome.

R Safadi 1, M Ligumsky 1, E Goldin 1, Y Ilan 1, Y S Haviv 1, S Nusair 1
PMCID: PMC2361055  PMID: 10211329

Abstract

A 67-year-old woman with a history of thyroiditis presented with recent intermittent epigastric pain and nausea. Hyperamylasaemia, oedema of the pancreas, and high serum levels of lipase and CA 19-9 were found. Xerostomia and dry eyes developed later, accompanied by an abnormal Schirmer's test. The diagnosis of Sjögren's syndrome was confirmed by increased anti-Ro and anti-La antibodies and the histological findings of parotid gland biopsy. Two additional cases of Sjögren's syndrome with elevated serum CA 19-9 are also described. These observations of elevated serum lipase and serum CA 19-9 in Sjögren's syndrome without evidence of malignancy may reflect pancreatic involvement in this disorder.

Full text

PDF
543

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrén-Sandberg A. CA 50 and CA 19-9 in serum as tumor markers for pancreatic cancer: a review of the literature. Acta Chir Scand Suppl. 1989;549:75–81. [PubMed] [Google Scholar]
  2. Cantagrel A., Moulinier L., Beljio K., Duffaut M., Laroche M., Bon E., Mazières B. Elévation du CA 19.9 au cours des rhumatismes inflammatories dysimmunitaires. A propos de 6 observations. Rev Rhum Ed Fr. 1994 Oct;61(9):599–606. [PubMed] [Google Scholar]
  3. Constantopoulos S. H., Tsianos E. V., Moutsopoulos H. M. Pulmonary and gastrointestinal manifestations of Sjögren's syndrome. Rheum Dis Clin North Am. 1992 Aug;18(3):617–635. [PubMed] [Google Scholar]
  4. Ho J. J., Norton K., Chung Y. S., Kim Y. S. Expression of CA19-9, DU-PAN-2, and SPan-1 antigens on two types of normal salivary mucins. Oncol Res. 1993;5(9):347–356. [PubMed] [Google Scholar]
  5. Kimura K., Ezoe K., Yokozeki H., Katayama I., Nishioka K. Elevated serum CA125 in progressive systemic sclerosis with pleural effusion. J Dermatol. 1995 Jan;22(1):28–31. doi: 10.1111/j.1346-8138.1995.tb03336.x. [DOI] [PubMed] [Google Scholar]
  6. Manthorpe R., Jacobsson L. T. Sjögren's syndrome. Baillieres Clin Rheumatol. 1995 Aug;9(3):483–496. doi: 10.1016/s0950-3579(05)80254-7. [DOI] [PubMed] [Google Scholar]
  7. Pal B., Griffiths I. D., Katrak A., Junglee D., Dandona P. Salivary amylase and pancreatic enzymes in Sjögren's syndrome. Clin Chem. 1987 Feb;33(2 Pt 1):305–307. [PubMed] [Google Scholar]
  8. Pleskow D. K., Berger H. J., Gyves J., Allen E., McLean A., Podolsky D. K. Evaluation of a serologic marker, CA19-9, in the diagnosis of pancreatic cancer. Ann Intern Med. 1989 May 1;110(9):704–709. doi: 10.7326/0003-4819-110-9-704. [DOI] [PubMed] [Google Scholar]
  9. Tsianos E. B., Vasakos S., Drosos A. A., Malamou-Mitsi V. D., Moutsopoulos H. M. The gastrointestinal involvement in primary Sjögren's syndrome. Scand J Rheumatol Suppl. 1986;61:151–155. [PubMed] [Google Scholar]
  10. Tsianos E. V., Moutsopoulos H. M. Sjögren's syndrome and the gut. Baillieres Clin Rheumatol. 1989 Aug;3(2):357–370. doi: 10.1016/s0950-3579(89)80026-3. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES